This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

NCT03780725 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Head and Neck Neoplasms

Interventions

DRUG: BI 754111
DRUG: [89Zr]Zr-BI 754111
DRUG: BI 754091

Sponsor

Boehringer Ingelheim